Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study
Frederick K. Korley(University of California, San Francisco), Raquel C. Gardner(University of Southern California), David O. Okonkwo(University of Pittsburgh Medical Center), Amy J. Markowitz(San Francisco General Hospital), Ramon Diaz‐Arrastia(California University of Pennsylvania), Sonia Jain(University of Antwerp), Pratik Mukherjee(University of California, San Francisco), Esther L. Yuh(University of California, San Francisco), Ava M. Puccio(University of Pittsburgh), Sabrina R. Taylor(University of California, San Francisco), John K. Yue(San Francisco General Hospital), Kevin Wang(Kavli Energy NanoScience Institute), Geoffrey T. Manley(University of California, San Francisco), Lindsay D. Nelson(Medical College of Wisconsin), Xiaoying Sun(Jiangnan University)
Cited by 215
Related Papers
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.3k
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
|Nature Reviews Neurology|2022|809
A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC)
|Intensive Care Medicine|2019|623
Symptomatology and Functional Outcome in Mild Traumatic Brain Injury: Results from the Prospective TRACK-TBI Study
|Journal of Neurotrauma|2013|517